Acacia hydaspica R. Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats

被引:39
作者
Afsar, Tayyaba [1 ]
Razak, Suhail [2 ,3 ]
Batoo, Khalid Mujasam [4 ]
Khan, Muhammad Rashid [1 ]
机构
[1] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad, Pakistan
[2] Quaid I Azam Univ, Fac Biol Sci, Dept Anim Sci, Islamabad, Pakistan
[3] King Saud Univ, Coll Appl Med Sci, Dept Community Hlth Sci, Riyadh, Saudi Arabia
[4] King Saud Univ, King Abdullah Inst Nanotechnol, POB 2455, Riyadh 11451, Saudi Arabia
来源
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE | 2017年 / 17卷
关键词
Doxorubicin; Cardiotoxicity; Oxidative stress; Cardiac function biomarkers; Antioxidants; Polyphenolics; ADRIAMYCIN-INDUCED CARDIOTOXICITY; INDUCED HEPATOTOXICITY; MYOCARDIAL-INFARCTION; INDUCED TOXICITY; AQUEOUS EXTRACT; PROTECTIVE ROLE; GLUTATHIONE; SILYMARIN; ANTIOXIDANTS; SUPEROXIDE;
D O I
10.1186/s12906-017-2061-0
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: The use of doxorubicin (DOX) an anthracycline antineoplastic agent is withdrawn due to its cardio-toxic side effects. Oxidative stress has been recognized as the primary cause of DOX induced cardiotoxicity. We have investigated whether polyphenol rich ethyl acetate extract of Acacia hydaspica (AHE) can attenuate doxorubicin-induced cardiotoxicity via inhibition of oxidative stress. Methods: AHE was administered orally to rats once daily for 6 weeks at doses of 200 and 400 mg/kg b.w. DOX (3 mg/kg b.w.i.p., single dose/week) was administered for 6 weeks (chronic model). The parameters studied to evaluate cardioprotective potential were the serum cardiac function biomarkers (CK, CKMB, AST and LDH), hematological parameters, cardiac tissue antioxidant enzymatic status and oxidative stress markers, and histopathological analysis to validate biochemical findings. Results: Chronic 6 week treatment of DOX significantly deteriorated cardiac function biomarkers and decreased the activities of antioxidant enzymes, whereas significant increase in oxidative stress biomarkers was noticed in comparison to control group. AHE dose dependently protected DOX-induced leakage of cardiac enzymes in serum and ameliorated DOX-induced oxidative stress; as evidenced by decreasing lipid peroxidation, H2O2 and NO content with increase in phase I and phase II antioxidant enzymes. Doxorubicin treatment produced severe morphological lesions, leucopenia, decrease in red blood cell counts and hemoglobin concentrations. AHE co-treatment protected the heart and blood elements from the toxic effects of doxorubicin as indicated by the recovery of hematological parameters to normal values and prevention of myocardial injuries in a dose dependent way. The protective potency of AHE (400 mg/kg b. w) was equivalent to silymarin. Conclusion: Results revealed that AHE showed protective effects against DOX induce cardiotoxicity. The protective effect might attribute to its polyphenolic constituents and antioxidant properties. AHE might be helpful in combination therapies as safer and efficient.
引用
收藏
页数:14
相关论文
共 80 条
  • [41] Prevention of doxorubicin induced cardiotoxicity by catechin
    Kozluca, O
    Olcay, E
    Surucu, S
    Guran, Z
    Kulaksiz, T
    Uskent, N
    [J]. CANCER LETTERS, 1996, 99 (01) : 1 - 6
  • [42] Kumar Joshi Pramod, 2002, Journal of Ecotoxicology & Environmental Monitoring, V12, P119
  • [43] Effect of aqueous extract of the Desmodium gangeticum DC root in the severity of myocardial infarction
    Kurian, GA
    Philip, S
    Varghese, T
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2005, 97 (03) : 457 - 461
  • [44] PROTEIN THIOL DEPLETION AND THE KILLING OF CULTURED-HEPATOCYTES BY HYDROGEN-PEROXIDE
    KYLE, ME
    NAKAE, D
    SAKAIDA, I
    SERRONI, A
    FARBER, JL
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (21) : 3797 - 3805
  • [45] Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice
    Lee, Chang Ki
    Son, Seung Hwa
    Park, Kwang Kyun
    Park, Jung Han Yoon
    Lim, Soon Sung
    Kim, Sook-Hyang
    Chung, Won Yoon
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 103 (01) : 48 - 54
  • [46] LOWRY OH, 1951, J BIOL CHEM, V193, P265
  • [47] MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357
  • [48] Mahsa Zarei Mahsa Zarei, 2013, Der Pharmacia Lettre, V5, P334
  • [49] Mensah AY, 2014, J PHARMACOGNOSY PHYT, V2, P101
  • [50] Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
    Minotti, G
    Menna, P
    Salvatorelli, E
    Cairo, G
    Gianni, L
    [J]. PHARMACOLOGICAL REVIEWS, 2004, 56 (02) : 185 - 229